Low AF - Search Results

1

Comparison between fixed-dose, intracoronary bolus-only versus standard weight-adjusted dose, intravenous bolus and infusion administration of abciximab in patients undergoing primary percutaneous coronary intervention.

Lee CH, Ngo HM, Sewianto A, Nguyen TH, Lee J, Teo SG, Low AF, Tan HC. Lee CH, et al. Among authors: low af. Int J Cardiol. 2010 Nov 19;145(2):355-357. doi: 10.1016/j.ijcard.2010.02.017. Epub 2010 Mar 15. Int J Cardiol. 2010. PMID: 20227778

2

Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent.

Tan HC, Low A, Ng KS, Budiono B, Sutandar A, Chia BL, Lim YT. Tan HC, et al. Singapore Med J. 2002 Nov;43(11):587-9. Singapore Med J. 2002. PMID: 12680530 Review.

3

Impact of reversibility of no-reflow phenomenon on 30-day mortality following percutaneous revascularisation for acute myocardial infarction--insights from a 1328-patient registry.

Lee CH, Wong HB, Tan HC, Jun JZ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT. Lee CH, et al. Ann Acad Med Singap. 2004 Sep;33(5 Suppl):S79-81. Ann Acad Med Singap. 2004. PMID: 15651223 No abstract available.

4

Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in diabetic patients undergoing primary angioplasty for myocardial infarction.

Lee CH, Teo SG, Hong E, Wong HB, Low A, Sutandar A, Tan HC, Lim YT. Lee CH, et al. J Invasive Cardiol. 2005 Aug;17(8):422-6. J Invasive Cardiol. 2005. PMID: 16079448

5

Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.

Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT. Lee CH, et al. J Interv Cardiol. 2005 Aug;18(4):261-6. doi: 10.1111/j.1540-8183.2005.00041.x. J Interv Cardiol. 2005. PMID: 16115155 Free article.

6

Comparison of the X-SIZER thrombectomy device with adjunct abciximab during primary angioplasty and stenting for ST-segment elevation myocardial infarction.

Low AF, Lim YT, Teo SG, Budiono B, Sutandar A, Tan HC. Low AF, et al. J Interv Cardiol. 2005 Aug;18(4):267-73. doi: 10.1111/j.1540-8183.2005.00044.x. J Interv Cardiol. 2005. PMID: 16115156 Free article.

7

Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions--a single-center experience.

Lee CH, Tan HC, Bee H, Zhang JJ, Soon CY, Teo SG, Low A, Lim YT. Lee CH, et al. J Invasive Cardiol. 2006 Feb;18(2):39-42. J Invasive Cardiol. 2006. PMID: 16446512

8

Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.

Lee CH, Lim J, Low A, Tan HC, Lim YT. Lee CH, et al. Heart. 2006 Apr;92(4):551-3. doi: 10.1136/hrt.2005.073619. Heart. 2006. PMID: 16537782 Free PMC article. No abstract available.

9

CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results.

Lee CH, Low A, Lim J, Wong HB, Lim YT, Tan HC. Lee CH, et al. Int J Cardiol. 2007 May 2;117(3):422-4. doi: 10.1016/j.ijcard.2006.05.065. Epub 2006 Aug 9. Int J Cardiol. 2007. PMID: 16904214 No abstract available.

10

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.

Lee CH, Low A, Tai BC, Co M, Chan MY, Lim J, Lim YT, Tan HC. Lee CH, et al. Eur Heart J. 2007 Jan;28(1):19-25. doi: 10.1093/eurheartj/ehl411. Epub 2006 Nov 28. Eur Heart J. 2007. PMID: 17132650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters